PRDX6 and type 2 diabetes mellitus: Recently, we demonstrated that peroxiredoxin 6 knockout mice (PRDX6−/−) developed a phenotype similar to an early stage of T2DM and were characterized by an impairment in muscle insulin sensitivity and glucose-stimulated insulin secretion [6].